TEKLA CAPITAL MANAGEMENT LLC MoonLake Immunotherapeutics Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$2.38M
portfolio value

MoonLake Immunotherapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 300K shares 2.38M $7.76 300K